Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peritoneal Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Surgery
1.2.3 Chemotherapy (Anticancer Drugs)
1.2.4 Radiotherapy (High-Energy Rays)
1.3 Market by Application
1.3.1 Global Peritoneal Cancer Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peritoneal Cancer Market Perspective (2018-2033)
2.2 Peritoneal Cancer Growth Trends by Region
2.2.1 Global Peritoneal Cancer Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Peritoneal Cancer Historic Market Size by Region (2018-2023)
2.2.3 Peritoneal Cancer Forecasted Market Size by Region (2024-2033)
2.3 Peritoneal Cancer Market Dynamics
2.3.1 Peritoneal Cancer Industry Trends
2.3.2 Peritoneal Cancer Market Drivers
2.3.3 Peritoneal Cancer Market Challenges
2.3.4 Peritoneal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peritoneal Cancer Players by Revenue
3.1.1 Global Top Peritoneal Cancer Players by Revenue (2018-2023)
3.1.2 Global Peritoneal Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Peritoneal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peritoneal Cancer Revenue
3.4 Global Peritoneal Cancer Market Concentration Ratio
3.4.1 Global Peritoneal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peritoneal Cancer Revenue in 2022
3.5 Peritoneal Cancer Key Players Head office and Area Served
3.6 Key Players Peritoneal Cancer Product Solution and Service
3.7 Date of Enter into Peritoneal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peritoneal Cancer Breakdown Data by Type
4.1 Global Peritoneal Cancer Historic Market Size by Type (2018-2023)
4.2 Global Peritoneal Cancer Forecasted Market Size by Type (2024-2033)
5 Peritoneal Cancer Breakdown Data by Application
5.1 Global Peritoneal Cancer Historic Market Size by Application (2018-2023)
5.2 Global Peritoneal Cancer Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Peritoneal Cancer Market Size (2018-2033)
6.2 North America Peritoneal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Peritoneal Cancer Market Size by Country (2018-2023)
6.4 North America Peritoneal Cancer Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peritoneal Cancer Market Size (2018-2033)
7.2 Europe Peritoneal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Peritoneal Cancer Market Size by Country (2018-2023)
7.4 Europe Peritoneal Cancer Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peritoneal Cancer Market Size (2018-2033)
8.2 Asia-Pacific Peritoneal Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Peritoneal Cancer Market Size by Region (2018-2023)
8.4 Asia-Pacific Peritoneal Cancer Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peritoneal Cancer Market Size (2018-2033)
9.2 Latin America Peritoneal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Peritoneal Cancer Market Size by Country (2018-2023)
9.4 Latin America Peritoneal Cancer Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peritoneal Cancer Market Size (2018-2033)
10.2 Middle East & Africa Peritoneal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Peritoneal Cancer Market Size by Country (2018-2023)
10.4 Middle East & Africa Peritoneal Cancer Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Peritoneal Cancer Introduction
11.1.4 AstraZeneca Revenue in Peritoneal Cancer Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Peritoneal Cancer Introduction
11.2.4 GlaxoSmithKline Revenue in Peritoneal Cancer Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Peritoneal Cancer Introduction
11.3.4 Oxford BioMedica Revenue in Peritoneal Cancer Business (2018-2023)
11.3.5 Oxford BioMedica Recent Development
11.4 Millennium Pharmaceuticals
11.4.1 Millennium Pharmaceuticals Company Detail
11.4.2 Millennium Pharmaceuticals Business Overview
11.4.3 Millennium Pharmaceuticals Peritoneal Cancer Introduction
11.4.4 Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2018-2023)
11.4.5 Millennium Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Peritoneal Cancer Introduction
11.5.4 Novartis Revenue in Peritoneal Cancer Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Peritoneal Cancer Introduction
11.6.4 Bayer Revenue in Peritoneal Cancer Business (2018-2023)
11.6.5 Bayer Recent Development
11.7 Incyte
11.7.1 Incyte Company Detail
11.7.2 Incyte Business Overview
11.7.3 Incyte Peritoneal Cancer Introduction
11.7.4 Incyte Revenue in Peritoneal Cancer Business (2018-2023)
11.7.5 Incyte Recent Development
11.8 EntreMed
11.8.1 EntreMed Company Detail
11.8.2 EntreMed Business Overview
11.8.3 EntreMed Peritoneal Cancer Introduction
11.8.4 EntreMed Revenue in Peritoneal Cancer Business (2018-2023)
11.8.5 EntreMed Recent Development
11.9 Oncolytics Biotech
11.9.1 Oncolytics Biotech Company Detail
11.9.2 Oncolytics Biotech Business Overview
11.9.3 Oncolytics Biotech Peritoneal Cancer Introduction
11.9.4 Oncolytics Biotech Revenue in Peritoneal Cancer Business (2018-2023)
11.9.5 Oncolytics Biotech Recent Development
11.10 Synta Pharmaceuticals
11.10.1 Synta Pharmaceuticals Company Detail
11.10.2 Synta Pharmaceuticals Business Overview
11.10.3 Synta Pharmaceuticals Peritoneal Cancer Introduction
11.10.4 Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2018-2023)
11.10.5 Synta Pharmaceuticals Recent Development
11.11 Oasmia Pharmaceutical
11.11.1 Oasmia Pharmaceutical Company Detail
11.11.2 Oasmia Pharmaceutical Business Overview
11.11.3 Oasmia Pharmaceutical Peritoneal Cancer Introduction
11.11.4 Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2018-2023)
11.11.5 Oasmia Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peritoneal Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy (Anticancer Drugs)
Table 4. Key Players of Radiotherapy (High-Energy Rays)
Table 5. Global Peritoneal Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Peritoneal Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Peritoneal Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Peritoneal Cancer Market Share by Region (2018-2023)
Table 9. Global Peritoneal Cancer Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Peritoneal Cancer Market Share by Region (2024-2033)
Table 11. Peritoneal Cancer Market Trends
Table 12. Peritoneal Cancer Market Drivers
Table 13. Peritoneal Cancer Market Challenges
Table 14. Peritoneal Cancer Market Restraints
Table 15. Global Peritoneal Cancer Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Peritoneal Cancer Market Share by Players (2018-2023)
Table 17. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Cancer as of 2022)
Table 18. Ranking of Global Top Peritoneal Cancer Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Peritoneal Cancer Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peritoneal Cancer Product Solution and Service
Table 22. Date of Enter into Peritoneal Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peritoneal Cancer Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Peritoneal Cancer Revenue Market Share by Type (2018-2023)
Table 26. Global Peritoneal Cancer Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Peritoneal Cancer Revenue Market Share by Type (2024-2033)
Table 28. Global Peritoneal Cancer Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Peritoneal Cancer Revenue Market Share by Application (2018-2023)
Table 30. Global Peritoneal Cancer Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Peritoneal Cancer Revenue Market Share by Application (2024-2033)
Table 32. North America Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Peritoneal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Peritoneal Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Peritoneal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Peritoneal Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Peritoneal Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Peritoneal Cancer Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Peritoneal Cancer Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Peritoneal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Peritoneal Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Peritoneal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Peritoneal Cancer Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Peritoneal Cancer Market Size by Country (2024-2033) & (US$ Million)
Table 47. AstraZeneca Company Detail
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Peritoneal Cancer Product
Table 50. AstraZeneca Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. GlaxoSmithKline Company Detail
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Peritoneal Cancer Product
Table 55. GlaxoSmithKline Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. Oxford BioMedica Company Detail
Table 58. Oxford BioMedica Business Overview
Table 59. Oxford BioMedica Peritoneal Cancer Product
Table 60. Oxford BioMedica Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 61. Oxford BioMedica Recent Development
Table 62. Millennium Pharmaceuticals Company Detail
Table 63. Millennium Pharmaceuticals Business Overview
Table 64. Millennium Pharmaceuticals Peritoneal Cancer Product
Table 65. Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 66. Millennium Pharmaceuticals Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Peritoneal Cancer Product
Table 70. Novartis Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Bayer Company Detail
Table 73. Bayer Business Overview
Table 74. Bayer Peritoneal Cancer Product
Table 75. Bayer Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Incyte Company Detail
Table 78. Incyte Business Overview
Table 79. Incyte Peritoneal Cancer Product
Table 80. Incyte Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 81. Incyte Recent Development
Table 82. EntreMed Company Detail
Table 83. EntreMed Business Overview
Table 84. EntreMed Peritoneal Cancer Product
Table 85. EntreMed Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 86. EntreMed Recent Development
Table 87. Oncolytics Biotech Company Detail
Table 88. Oncolytics Biotech Business Overview
Table 89. Oncolytics Biotech Peritoneal Cancer Product
Table 90. Oncolytics Biotech Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 91. Oncolytics Biotech Recent Development
Table 92. Synta Pharmaceuticals Company Detail
Table 93. Synta Pharmaceuticals Business Overview
Table 94. Synta Pharmaceuticals Peritoneal Cancer Product
Table 95. Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 96. Synta Pharmaceuticals Recent Development
Table 97. Oasmia Pharmaceutical Company Detail
Table 98. Oasmia Pharmaceutical Business Overview
Table 99. Oasmia Pharmaceutical Peritoneal Cancer Product
Table 100. Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2018-2023) & (US$ Million)
Table 101. Oasmia Pharmaceutical Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peritoneal Cancer Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Peritoneal Cancer Market Share by Type: 2022 VS 2033
Figure 3. Surgery Features
Figure 4. Chemotherapy (Anticancer Drugs) Features
Figure 5. Radiotherapy (High-Energy Rays) Features
Figure 6. Global Peritoneal Cancer Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Peritoneal Cancer Market Share by Application: 2022 VS 2033
Figure 8. Cancer Research Centers Case Studies
Figure 9. Cancer Hospital Case Studies
Figure 10. Surgical Centers Case Studies
Figure 11. Clinics Case Studies
Figure 12. Peritoneal Cancer Report Years Considered
Figure 13. Global Peritoneal Cancer Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Peritoneal Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Peritoneal Cancer Market Share by Region: 2022 VS 2033
Figure 16. Global Peritoneal Cancer Market Share by Players in 2022
Figure 17. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Cancer as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Peritoneal Cancer Revenue in 2022
Figure 19. North America Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Peritoneal Cancer Market Share by Country (2018-2033)
Figure 21. United States Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Peritoneal Cancer Market Share by Country (2018-2033)
Figure 25. Germany Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Peritoneal Cancer Market Share by Region (2018-2033)
Figure 33. China Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Peritoneal Cancer Market Share by Country (2018-2033)
Figure 41. Mexico Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Peritoneal Cancer Market Share by Country (2018-2033)
Figure 45. Turkey Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Peritoneal Cancer Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. AstraZeneca Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 49. Oxford BioMedica Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 50. Millennium Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 52. Bayer Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 53. Incyte Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 54. EntreMed Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 55. Oncolytics Biotech Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 56. Synta Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 57. Oasmia Pharmaceutical Revenue Growth Rate in Peritoneal Cancer Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed